Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

Laparoscopic esophagogastrostomy using a knifeless linear stapler after proximal gastrectomy.

Ohi M, Toiyama Y, Kitajima T, Shigemori T, Yasuda H, Okugawa Y, Fujikawa H, Okita Y, Yokoe T, Hiro J, Araki T, Kusunoki M.

Surg Today. 2019 Jun 20. doi: 10.1007/s00595-019-01836-3. [Epub ahead of print]

PMID:
31222502
2.

Rac GTPase-Activating Protein 1 (RACGAP1) as an Oncogenic Enhancer in Esophageal Carcinoma.

Yin C, Toiyama Y, Okugawa Y, Shigemori T, Yamamoto A, Ide S, Kitajima T, Fujikawa H, Yasuda H, Okita Y, Hiro J, Yoshiyama S, Ohi M, Araki T, Yao L, Kusunoki M.

Oncology. 2019 Jun 19:1-9. doi: 10.1159/000500592. [Epub ahead of print]

PMID:
31216559
3.

Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer.

Okugawa Y, Toiyama Y, Yamamoto A, Shigemori T, Ichikawa T, Yin C, Suzuki A, Fujikawa H, Yasuda H, Hiro J, Yoshiyama S, Ohi M, Araki T, McMillan DC, Kusunoki M.

Clin Nutr. 2019 May 21. pii: S0261-5614(19)30220-1. doi: 10.1016/j.clnu.2019.05.009. [Epub ahead of print]

PMID:
31155370
4.

Circulating miR-203 derived from metastatic tissues promotes myopenia in colorectal cancer patients.

Okugawa Y, Toiyama Y, Hur K, Yamamoto A, Yin C, Ide S, Kitajima T, Fujikawa H, Yasuda H, Koike Y, Okita Y, Hiro J, Yoshiyama S, Araki T, Miki C, McMillan DC, Goel A, Kusunoki M.

J Cachexia Sarcopenia Muscle. 2019 Mar 25. doi: 10.1002/jcsm.12403. [Epub ahead of print]

5.

Phase I study of preoperative chemoradiotherapy with sequential oxaliplatin and irinotecan with S-1 for locally advanced rectal cancer.

Fujikawa H, Toiyama Y, Inoue Y, Omura Y, Ide S, Kitajima T, Yasuda H, Okugawa Y, Okita Y, Yoshiyama S, Hiro J, Kobayashi M, Ohi M, Araki T, Kusunoki M.

Oncol Lett. 2019 Apr;17(4):3930-3936. doi: 10.3892/ol.2019.10028. Epub 2019 Feb 8.

6.

Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer.

Okugawa Y, Toiyama Y, Yamamoto A, Shigemori T, Ide S, Kitajima T, Fujikawa H, Yasuda H, Hiro J, Yoshiyama S, Yokoe T, Saigusa S, Tanaka K, Shirai Y, Kobayashi M, Ohi M, Araki T, McMillan DC, Miki C, Goel A, Kusunoki M.

Ann Surg. 2019 Feb 16. doi: 10.1097/SLA.0000000000003239. [Epub ahead of print]

PMID:
30817357
7.

Possibility of limited gastrectomy for early gastric cancer located in the upper third of the stomach, based on the distribution of sentinel node basins.

Ohi M, Toiyama Y, Omura Y, Ichikawa T, Yasuda H, Okugawa Y, Fujikawa H, Okita Y, Yoshiyama S, Hiro J, Araki T, Kusunoki M.

Surg Today. 2019 Jun;49(6):529-535. doi: 10.1007/s00595-019-1768-6. Epub 2019 Jan 25.

PMID:
30684050
8.

Genetic influence of cytokine polymorphisms on the clinical outcome of Japanese gastrointestinal cancer patients in palliative care.

Hishida A, Okugawa Y, Morimoto Y, Shirai Y, Okamoto K, Momokita S, Ogawa A, Tanaka K, Nishikawa R, Toiyama Y, Inoue Y, Sakurai H, Urata H, Tanaka M, McMillan DC, Miki C.

Oncol Lett. 2019 Jan;17(1):623-629. doi: 10.3892/ol.2018.9614. Epub 2018 Oct 24.

9.

Polymorphisms in folic acid metabolism genes do not associate with cancer cachexia in Japanese gastrointestinal patients.

Morishita T, Hishida A, Okugawa Y, Morimoto Y, Shirai Y, Okamoto K, Momokita S, Ogawa A, Tanaka K, Nishikawa R, Toiyama Y, Inoue Y, Sakurai H, Urata H, Tanaka M, Miki C.

Nagoya J Med Sci. 2018 Nov;80(4):529-539. doi: 10.18999/nagjms.80.4.529.

10.

Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer.

Takeda S, Shigeyasu K, Okugawa Y, Yoshida K, Mori Y, Yano S, Noma K, Umeda Y, Kondo Y, Kishimoto H, Teraishi F, Nagasaka T, Tazawa H, Kagawa S, Fujiwara T, Goel A.

Cancer Lett. 2019 Mar 1;444:127-135. doi: 10.1016/j.canlet.2018.12.009. Epub 2018 Dec 21.

PMID:
30583079
11.

Soluble PD-L1 Expression in Circulation as a Predictive Marker for Recurrence and Prognosis in Gastric Cancer: Direct Comparison of the Clinical Burden Between Tissue and Serum PD-L1 Expression.

Shigemori T, Toiyama Y, Okugawa Y, Yamamoto A, Yin C, Narumi A, Ichikawa T, Ide S, Shimura T, Fujikawa H, Yasuda H, Hiro J, Yoshiyama S, Ohi M, Araki T, Kusunoki M.

Ann Surg Oncol. 2019 Mar;26(3):876-883. doi: 10.1245/s10434-018-07112-x. Epub 2018 Dec 18.

PMID:
30565045
12.

Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.

Okugawa Y, Toiyama Y, Shigeyasu K, Yamamoto A, Shigemori T, Yin C, Ichikawa T, Yasuda H, Fujikawa H, Yoshiyama S, Hiro J, Ohi M, Araki T, Kusunoki M, Goel A.

J Transl Med. 2018 Dec 18;16(1):366. doi: 10.1186/s12967-018-1740-z.

13.

Clinical Implications of Pretreatment: Lymphocyte-to-Monocyte Ratio in Patients With Rectal Cancer Receiving Preoperative Chemoradiotherapy.

Yamamoto A, Toiyama Y, Okugawa Y, Oki S, Ide S, Saigusa S, Araki T, Kusunoki M.

Dis Colon Rectum. 2019 Feb;62(2):171-180. doi: 10.1097/DCR.0000000000001245.

PMID:
30451750
14.

Close Relationship Between Immunological/Inflammatory Markers and Myopenia and Myosteatosis in Patients With Colorectal Cancer: A Propensity Score Matching Analysis.

Okugawa Y, Toiyama Y, Yamamoto A, Shigemori T, Kitamura A, Ichikawa T, Ide S, Kitajima T, Fujikawa H, Yasuda H, Okita Y, Hiro J, Araki T, McMillan DC, Miki C, Kusunoki M.

JPEN J Parenter Enteral Nutr. 2019 May;43(4):508-515. doi: 10.1002/jpen.1459. Epub 2018 Oct 18.

PMID:
30334265
15.

Risk factors and measures of pulmonary complications after thoracoscopic esophagectomy for esophageal cancer.

Ohi M, Toiyama Y, Omura Y, Ichikawa T, Yasuda H, Okugawa Y, Fujikawa H, Okita Y, Yoshiyama S, Hiro J, Araki T, Kusunoki M.

Surg Today. 2019 Feb;49(2):176-186. doi: 10.1007/s00595-018-1721-0. Epub 2018 Sep 25.

PMID:
30255330
16.

Comprehensive analysis identifying aberrant DNA methylation in rectal mucosa from ulcerative colitis patients with neoplasia.

Toiyama Y, Okugawa Y, Kondo S, Okita Y, Araki T, Kusunoki K, Uchino M, Ikeuchi H, Hirota S, Mitsui A, Takehana K, Umezawa T, Kusunoki M.

Oncotarget. 2018 Sep 4;9(69):33149-33159. doi: 10.18632/oncotarget.26032. eCollection 2018 Sep 4.

17.

Identification of Predictors of Recurrence in Patients with Lower Rectal Cancer Undergoing Neoadjuvant Chemotherapy: A Direct Comparison of Short-Course and Long-Course Chemoradiotherapy.

Yamamoto A, Toiyama Y, Okugawa Y, Saigusa S, Ide S, Fujikawa H, Hiro J, Yasuda H, Yoshiyama S, Ohi M, Araki T, Kusunoki M.

Oncology. 2019;96(2):70-78. doi: 10.1159/000492617. Epub 2018 Sep 18.

PMID:
30227430
18.

Downregulation of trefoil factor-3 expression in the rectum is associated with the development of ulcerative colitis-associated cancer.

Kondo S, Araki T, Toiyama Y, Tanaka K, Kawamura M, Okugawa Y, Okita Y, Saigusa S, Inoue Y, Uchida K, Mohri Y, Kusunoki M.

Oncol Lett. 2018 Sep;16(3):3658-3664. doi: 10.3892/ol.2018.9120. Epub 2018 Jul 10.

19.

Clinical Impact of Preoperative Albumin-Globulin Ratio in Patients with Rectal Cancer Treated with Preoperative Chemoradiotherapy.

Toiyama Y, Oki S, Okugawa Y, Ide S, Yasuda H, Fujikawa H, Yoshiyama S, Hiro J, Ohi M, Inoue Y, Araki T, Kusunoki M.

Oncology. 2018;95(5):270-280. doi: 10.1159/000490149. Epub 2018 Jul 11.

PMID:
29996133
20.

AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer.

Shigeyasu K, Okugawa Y, Toden S, Miyoshi J, Toiyama Y, Nagasaka T, Takahashi N, Kusunoki M, Takayama T, Yamada Y, Fujiwara T, Chen L, Goel A.

JCI Insight. 2018 Jun 21;3(12). pii: 99976. doi: 10.1172/jci.insight.99976. eCollection 2018 Jun 21.

21.

Diphosphination of Arynes with Diphosphines.

Okugawa Y, Hayashi Y, Kawauchi S, Hirano K, Miura M.

Org Lett. 2018 Jun 15;20(12):3670-3673. doi: 10.1021/acs.orglett.8b01470. Epub 2018 Jun 6.

PMID:
29874086
22.

MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review.

Toiyama Y, Okugawa Y, Fleshman J, Richard Boland C, Goel A.

Biochim Biophys Acta Rev Cancer. 2018 Dec;1870(2):274-282. doi: 10.1016/j.bbcan.2018.05.006. Epub 2018 May 29. Review.

PMID:
29852194
23.

Feasibility of Assessing Prognostic Nutrition Index in Patients With Rectal Cancer Who Receive Preoperative Chemoradiotherapy.

Okugawa Y, Toiyama Y, Oki S, Ide S, Yamamoto A, Ichikawa T, Kitajima T, Fujikawa H, Yasuda H, Saigusa S, Hiro J, Yoshiyama S, Kobayashi M, Araki T, Kusunoki M.

JPEN J Parenter Enteral Nutr. 2018 Aug;42(6):998-1007. doi: 10.1002/jpen.1041. Epub 2018 Jan 7.

PMID:
29786882
24.

Colony-stimulating factor-1 and colony-stimulating factor-1 receptor co-expression is associated with disease progression in gastric cancer.

Okugawa Y, Toiyama Y, Ichikawa T, Kawamura M, Yasuda H, Fujikawa H, Saigusa S, Ohi M, Araki T, Tanaka K, Inoue Y, Tanaka M, Miki C, Kusunoki M.

Int J Oncol. 2018 Aug;53(2):737-749. doi: 10.3892/ijo.2018.4406. Epub 2018 May 16.

PMID:
29767252
25.

Clinical Impact of Muscle Quantity and Quality in Colorectal Cancer Patients: A Propensity Score Matching Analysis.

Okugawa Y, Toiyama Y, Yamamoto A, Shigemori T, Yin C, Narumi A, Omura Y, Ide S, Kitajima T, Fujikawa H, Yasuda H, Hiro J, Yoshiyama S, Kobayashi M, Araki T, McMillan DC, Miki C, Kusunoki M.

JPEN J Parenter Enteral Nutr. 2018 Nov;42(8):1322-1333. doi: 10.1002/jpen.1171. Epub 2018 May 15.

PMID:
29761898
26.

Reply.

Toiyama Y, Okugawa Y, Boland CR, Goel A.

Gastroenterology. 2018 Jun;154(8):2274-2275. doi: 10.1053/j.gastro.2018.05.013. Epub 2018 May 8. No abstract available.

PMID:
29750909
27.

Dynamic bacterial community changes in the autothermal thermophilic aerobic digestion process with cell lysis activities, shaking and temperature increase.

Cheng H, Asakura Y, Kanda K, Fukui R, Kawano Y, Okugawa Y, Tashiro Y, Sakai K.

J Biosci Bioeng. 2018 Aug;126(2):196-204. doi: 10.1016/j.jbiosc.2018.02.012. Epub 2018 Apr 13.

PMID:
29657124
28.

Re: Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study.

Okugawa Y, Toiyama Y, Kusunoki M, Goel A.

Gut. 2018 Mar 13. pii: gutjnl-2018-316205. doi: 10.1136/gutjnl-2018-316205. [Epub ahead of print] No abstract available.

PMID:
29535153
29.

Amycolatopsis silviterrae sp. nov., isolated from forest soil.

Jamjan W, Suriyachadkun C, Tanasupawat S, Sakai K, Tashiro Y, Okugawa Y, Tongpim S.

Int J Syst Evol Microbiol. 2018 May;68(5):1455-1460. doi: 10.1099/ijsem.0.002687. Epub 2018 Mar 13.

PMID:
29533177
30.

Clinical Burden of Modified Glasgow Prognostic Scale in Colorectal Cancer.

Okugawa Y, Shirai Y, Toiyama Y, Saigusa S, Hishida A, Yokoe T, Tanaka K, Tanaka M, Yasuda H, Fujikawa H, Hiro J, Kobayashi M, Araki T, Inoue Y, McMillan DC, Kusunoki M, Miki C.

Anticancer Res. 2018 Mar;38(3):1599-1610.

PMID:
29491091
31.

Prognostic impact of sarcopenia and its correlation with circulating miR-21 in colorectal cancer patients.

Okugawa Y, Yao L, Toiyama Y, Yamamoto A, Shigemori T, Yin C, Omura Y, Ide S, Kitajima T, Shimura T, Fujikawa H, Yasuda H, Hiro J, Yoshiyama S, Kobayashi M, Tanaka K, Inoue Y, Araki T, Miki C, Kusunoki M.

Oncol Rep. 2018 Apr;39(4):1555-1564. doi: 10.3892/or.2018.6270. Epub 2018 Feb 14.

PMID:
29484416
32.

A RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer.

Yamada A, Yu P, Lin W, Okugawa Y, Boland CR, Goel A.

Sci Rep. 2018 Jan 12;8(1):575. doi: 10.1038/s41598-017-18407-6.

33.

A Unique Autothermal Thermophilic Aerobic Digestion Process Showing a Dynamic Transition of Physicochemical and Bacterial Characteristics from the Mesophilic to the Thermophilic Phase.

Tashiro Y, Kanda K, Asakura Y, Kii T, Cheng H, Poudel P, Okugawa Y, Tashiro K, Sakai K.

Appl Environ Microbiol. 2018 Mar 1;84(6). pii: e02537-17. doi: 10.1128/AEM.02537-17. Print 2018 Mar 15.

34.

Successful identification of a predictive biomarker for lymph node metastasis in colorectal cancer using a proteomic approach.

Mori K, Toiyama Y, Otake K, Ide S, Imaoka H, Okigami M, Okugawa Y, Fujikawa H, Saigusa S, Hiro J, Kobayashi M, Ohi M, Tanaka K, Inoue Y, Kobayashi Y, Mohri Y, Kobayashi I, Goel A, Kusunoki M.

Oncotarget. 2017 Oct 30;8(63):106935-106947. doi: 10.18632/oncotarget.22149. eCollection 2017 Dec 5.

35.

Clinical Significance of C-Reactive Protein-to-Albumin Ratio with Rectal Cancer Patient Undergoing Chemoradiotherapy Followed by Surgery.

Ide S, Toiyama Y, Okugawa Y, Oki S, Yasuda H, Fujikawa H, Yoshiyama S, Hiro J, Kobayashi M, Ohi M, Araki T, Kusunoki M.

Anticancer Res. 2017 Oct;37(10):5797-5804.

PMID:
28982904
36.

FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer.

Sarkar S, O'Connell MR, Okugawa Y, Lee BS, Toiyama Y, Kusunoki M, Daboval RD, Goel A, Singh P.

Mol Cancer Res. 2017 Dec;15(12):1678-1691. doi: 10.1158/1541-7786.MCR-17-0287. Epub 2017 Aug 29.

37.

A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.

Toiyama Y, Okugawa Y, Tanaka K, Araki T, Uchida K, Hishida A, Uchino M, Ikeuchi H, Hirota S, Kusunoki M, Boland CR, Goel A.

Gastroenterology. 2017 Dec;153(6):1634-1646.e8. doi: 10.1053/j.gastro.2017.08.037. Epub 2017 Aug 25.

38.

vic-Diphosphination of Alkenes with Silylphosphine under Visible-Light-Promoted Photoredox Catalysis.

Otomura N, Okugawa Y, Hirano K, Miura M.

Org Lett. 2017 Sep 15;19(18):4802-4805. doi: 10.1021/acs.orglett.7b02223. Epub 2017 Aug 24.

PMID:
28837350
39.

A novel probiotic Bacillus siamensis B44v isolated from Thai pickled vegetables (Phak-dong) for potential use as a feed supplement in aquaculture.

Meidong R, Doolgindachbaporn S, Jamjan W, Sakai K, Tashiro Y, Okugawa Y, Tongpim S.

J Gen Appl Microbiol. 2017 Sep 5;63(4):246-253. doi: 10.2323/jgam.2016.12.002. Epub 2017 Jul 27.

40.

Fish oil-enriched nutrition combined with systemic chemotherapy for gastrointestinal cancer patients with cancer cachexia.

Shirai Y, Okugawa Y, Hishida A, Ogawa A, Okamoto K, Shintani M, Morimoto Y, Nishikawa R, Yokoe T, Tanaka K, Urata H, Toiyama Y, Inoue Y, Tanaka M, Mohri Y, Goel A, Kusunoki M, McMillan DC, Miki C.

Sci Rep. 2017 Jul 6;7(1):4826. doi: 10.1038/s41598-017-05278-0.

41.

N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration.

Rigoutsos I, Lee SK, Nam SY, Anfossi S, Pasculli B, Pichler M, Jing Y, Rodriguez-Aguayo C, Telonis AG, Rossi S, Ivan C, Catela Ivkovic T, Fabris L, Clark PM, Ling H, Shimizu M, Redis RS, Shah MY, Zhang X, Okugawa Y, Jung EJ, Tsirigos A, Huang L, Ferdin J, Gafà R, Spizzo R, Nicoloso MS, Paranjape AN, Shariati M, Tiron A, Yeh JJ, Teruel-Montoya R, Xiao L, Melo SA, Menter D, Jiang ZQ, Flores ER, Negrini M, Goel A, Bar-Eli M, Mani SA, Liu CG, Lopez-Berestein G, Berindan-Neagoe I, Esteller M, Kopetz S, Lanza G, Calin GA.

Genome Biol. 2017 May 24;18(1):98. doi: 10.1186/s13059-017-1224-0.

42.

Brønsted Base Mediated Stereoselective Diphosphination of Terminal Alkynes with Diphosphanes.

Okugawa Y, Hirano K, Miura M.

Org Lett. 2017 Jun 2;19(11):2973-2976. doi: 10.1021/acs.orglett.7b01209. Epub 2017 May 17.

PMID:
28513163
43.

Clinical burden of preoperative albumin-globulin ratio in esophageal cancer patients.

Oki S, Toiyama Y, Okugawa Y, Shimura T, Okigami M, Yasuda H, Fujikawa H, Okita Y, Yoshiyama S, Hiro J, Kobayashi M, Ohi M, Araki T, Inoue Y, Mohri Y, Kusunoki M.

Am J Surg. 2017 Nov;214(5):891-898. doi: 10.1016/j.amjsurg.2017.04.007. Epub 2017 Apr 25.

PMID:
28460738
44.

Emerging Role of MicroRNAs as Liquid Biopsy Biomarkers in Gastrointestinal Cancers.

Shigeyasu K, Toden S, Zumwalt TJ, Okugawa Y, Goel A.

Clin Cancer Res. 2017 May 15;23(10):2391-2399. doi: 10.1158/1078-0432.CCR-16-1676. Epub 2017 Jan 31. Review.

45.

Objective Predictive Score as a Feasible Biomarker for Short-term Survival in TerminalIy Ill Patients with Cancer.

Okugawa Y, Shirai Y, Nodono H, Matsutani F, Itoh M, Hishida A, Morimoto Y, Nishikawa R, Yokoe T, Tanaka K, Urata H, Toiyama Y, Araki T, Inoue Y, Tanaka M, Kusunoki M, Miki C.

Anticancer Res. 2017 Jan;37(1):267-275.

PMID:
28011502
46.

MicroRNA-7 Is Associated with Malignant Potential and Poor Prognosis in Human Colorectal Cancer.

Nagano Y, Toiyama Y, Okugawa Y, Imaoka H, Fujikawa H, Yasuda H, Yoshiyama S, Hiro J, Kobayashi M, Ohi M, Araki T, Inoue Y, Mohri Y, Kusunoki M.

Anticancer Res. 2016 Dec;36(12):6521-6526.

PMID:
27919977
47.

Copper-Catalyzed Vicinal Diphosphination of Styrenes: Access to 1,2-Bis(diphenylphosphino)ethane-Type Bidentate Ligands from Olefins.

Okugawa Y, Hirano K, Miura M.

Angew Chem Int Ed Engl. 2016 Oct 17;55(43):13558-13561. doi: 10.1002/anie.201606976. Epub 2016 Sep 27.

PMID:
27671924
48.

Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis.

Pichler M, Stiegelbauer V, Vychytilova-Faltejskova P, Ivan C, Ling H, Winter E, Zhang X, Goblirsch M, Wulf-Goldenberg A, Ohtsuka M, Haybaeck J, Svoboda M, Okugawa Y, Gerger A, Hoefler G, Goel A, Slaby O, Calin GA.

Clin Cancer Res. 2017 Mar 1;23(5):1323-1333. doi: 10.1158/1078-0432.CCR-16-0497. Epub 2016 Sep 6.

49.

Metastasis-associated protein is a predictive biomarker for metastasis and recurrence in gastric cancer.

Okugawa Y, Mohri Y, Tanaka K, Kawamura M, Saigusa S, Toiyama Y, Ohi M, Inoue Y, Miki C, Kusunoki M.

Oncol Rep. 2016 Oct;36(4):1893-900. doi: 10.3892/or.2016.5054. Epub 2016 Aug 25.

PMID:
27574100
50.

Development of a systematic feedback isolation approach for targeted strains from mixed culture systems.

Poudel P, Tashiro Y, Miyamoto H, Miyamoto H, Okugawa Y, Sakai K.

J Biosci Bioeng. 2017 Jan;123(1):63-70. doi: 10.1016/j.jbiosc.2016.07.019. Epub 2016 Aug 25.

PMID:
27570222

Supplemental Content

Loading ...
Support Center